We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.47B
AUM Growth
-$26.4M
Cap. Flow
-$317M
Cap. Flow %
-3.74%
Top 10 Hldgs %
16.75%
Holding
2,295
New
113
Increased
604
Reduced
562
Closed
131

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$44.9M
2
BKNG icon
Booking.com
BKNG
+$30.5M
3
TWX
Time Warner Inc
TWX
+$22.2M
4
MON
Monsanto Co
MON
+$15.5M
5
AAPL icon
Apple
AAPL
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 17.18%
2 Financials 16.58%
3 Healthcare 12.69%
4 Industrials 10.83%
5 Consumer Discretionary 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WDR
1201
DELISTED
Waddell & Reed Financial, Inc.
WDR
$701K 0.01%
38,993
ACAD icon
1202
Acadia Pharmaceuticals
ACAD
$5.07B
$700K 0.01%
+45,819
New +$817K
VTLE
1203
DELISTED
Vital Energy
VTLE
$700K 0.01%
+3,637
New +$682K
SIR
1204
DELISTED
SELECT INCOME REIT
SIR
$699K 0.01%
70,784
WD icon
1205
Walker & Dunlop
WD
$1.45B
$698K 0.01%
12,545
DMC
1206
Del Monte Corp
DMC
$1.42B
$697K 0.01%
15,644
CAL icon
1207
Caleres
CAL
$455M
$694K 0.01%
20,189
DDD icon
1208
3D Systems Corp
DDD
$603M
$694K 0.01%
50,283
-64,917
-56% -$805K
WPG
1209
DELISTED
Washington Prime Group Inc.
WPG
$693K 0.01%
9,497
-12,881
-58% -$832K
ATRA icon
1210
Atara Biotherapeutics
ATRA
$83.1M
$692K 0.01%
753
+151
+25% +$162K
ADC icon
1211
Agree Realty
ADC
$9.25B
$688K 0.01%
13,037
INN
1212
Summit Hotel Properties
INN
$655M
$688K 0.01%
48,101
NPO icon
1213
Enpro
NPO
$7.23B
$688K 0.01%
9,829
CORT icon
1214
Corcept Therapeutics
CORT
$12.1B
$683K 0.01%
43,446
BRKL
1215
DELISTED
Brookline Bancorp
BRKL
$682K 0.01%
36,642
+3,641
+11% +$63.9K
BEAT
1216
DELISTED
BioTelemetry, Inc.
BEAT
$681K 0.01%
+15,132
New +$603K
THRM icon
1217
Gentherm
THRM
$1.27B
$679K 0.01%
17,276
ACCO icon
1218
Acco Brands
ACCO
$399M
$678K 0.01%
48,975
+5,210
+12% +$66.9K
STBA icon
1219
S&T Bancorp
STBA
$1.82B
$677K 0.01%
15,660
OCLR
1220
DELISTED
Oclaro Inc.
OCLR
$677K 0.01%
75,775
ARCH
1221
DELISTED
Arch Resources, Inc.
ARCH
$675K 0.01%
8,609
GME icon
1222
GameStop
GME
$8.32B
$674K 0.01%
185,084
-67,800
-27% -$232K
PEGI
1223
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$674K 0.01%
35,949
SBCF icon
1224
Seacoast Banking Corp of Florida
SBCF
$3.44B
$673K 0.01%
21,315
+2,219
+12% +$65.9K
SGMO
1225
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$670K 0.01%
47,157
+7,971
+20% +$132K

Similar funds

MetLife Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, MetLife Investment Management held 2,295 positions worth $8.47B, down 0.31% from $8.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

MetLife Investment Management withdrew a net $317M in Q2 2018, closing 131 positions and reducing 562 holdings. Its most notable exit was DuPont de Nemours, an estimated $44.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, MetLife Investment Management opened a new position in Bank of New York Mellon worth $16M.

  • MetLife Investment Management's largest Q2 2018 buy was Bank of New York Mellon: 297,519 shares worth $16M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $33.8M increase.
  • MetLife Investment Management's biggest Q2 2018 reduction was Apple, cutting an estimated $14.5M.
  • MetLife Investment Management fully exited DuPont de Nemours in Q2 2018, selling an estimated $44.9M.
  • MetLife Investment Management's ten largest holdings make up 17% of its $8.47B portfolio in Q2 2018.
  • MetLife Investment Management opened 113 new positions and closed 131 in Q2 2018.
  • MetLife Investment Management's portfolio value fell 0.31% quarter-over-quarter to $8.47B.

Based on MetLife Investment Management's 13F filing for Q2 2018, filed 15 Aug 2018.